Bestron 0.45 mg+20 mg is a Product of the Generic Conjugated Estrogen + Bazedoxifene

Bestron 0.45 mg+20 mg belongs to the generic category of Conjugated Estrogen + Bazedoxifene. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Bestron 0.45 mg+20 mg. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Conjugated Estrogen + Bazedoxifene and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Bestron 0.45 mg+20 mg

Bestron 0.45 mg+20 mg may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Bestron 0.45 mg+20 mg is provided below to help users gain a clear understanding of this medicine.

What Is Bestron 0.45 mg+20 mg Indications and Uses?

This preparation is indicated for treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis.

Pharmacology (Source, Chemical and Physical Composition) Of Bestron 0.45 mg+20 mg

Conjugated Estrogens and Bazedoxifene function by binding to and activating estrogen receptors (ER) α and β. Bazedoxifene is an estrogen agonist / antagonist that acts as an agonist in some estrogen-sensitive tissues and an antagonist in others (e.g. uterus).

Dosage And Administration of Bestron 0.45 mg+20 mg

Take Bestron once daily, without regard to meals. Tablets should be swallowed whole. Women taking Bestron for prevention of postmenopausal osteoporosis should add supplemental calcium and/or vitamin-D to their diet if daily intake is inadequate.Use in Children: Bestron is not indicated for use in children.

Drug Interactions of Bestron 0.45 mg+20 mg

No drug interaction studies were conducted with This tablet. Estrogens are metabolized partially by CYP3A4. Concomitant use of this tablet with CYP3A4 inhibitors may increase the exposure of conjugated estrogens and thereby may increase the risk of endometrial hyperplasia.

Side Effects of Bestron 0.45 mg+20 mg

High blood pressure, blood clots, liver problems, thyroid problems, fluid retention, hypocalcemia, dementia, breast lumps, unusual vaginal bleeding, severe headache, muscle spasms, weakness and fatigue, nausea, diarrhea, throat pain, dizziness etc.

Use During Pregnancy and Lactation

Pregnancy Category X. Bestron must not be used in women who are or may become pregnant. Bestron should not be used by lactating women. It is not known whether this drug is excreted in human milk. Estrogen administration to nursing mothers has been shown to decrease the quantity and quality of the milk.

Precautions And Warnings for Bestron 0.45 mg+20 mg

Estrogen therapy should not be used for the prevention of cardiovascular disease or dementia. There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens.

Therapeutic Class

Female Sex hormones

Storage Conditions of It

Keep out of the reach of children. Do not store above 30°C. Keep away from light and out of the reach of children. After opening foil pouch, product must be used within 60 days.

Bestron 0.45 mg+20 mg is a Product of the Generic Conjugated Estrogen + Bazedoxifene